The Boston Globe reports that as researchers move to understand the full nature and promise of induced pluripotent stem (iPS) cells, they are finding a variety of signals that suggest they are different from embryonic stem cells in key ways. The work of George Daley, MD, PhD, and his colleagues to distinguish the differences between iPS and embryonic stem cells is highlighted. More